Discontinued — last reported Q2 '18
Other
Fair Value Measurement Disclosure
Medtronic Fair Value Measurement Disclosure increased by 11.2% to $388.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 391.1%, from $79.00M to $388.00M. Over 5 years (FY 2020 to FY 2025), Fair Value Measurement Disclosure shows an upward trend with a 11.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2015
Last reportedQ2 2018
How to read this metric
Higher levels indicate a larger portion of the balance sheet is subject to market-based valuation volatility.
Detailed definition
This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring o...
Peer comparison
Standard disclosure for financial institutions with significant investment holdings.
Metric ID:
fair_value_measurement_disclosureHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $296.00M | $181.00M | $163.00M | $177.00M | $129.00M | $61.00M | $51.00M | $267.00M | $236.00M | $306.00M | $82.00M | $109.00M | $66.00M | $98.00M | $110.00M | $79.00M | $417.00M | $523.00M | $349.00M | $388.00M |
| QoQ Change | — | -38.9% | -9.9% | +8.6% | -27.1% | -52.7% | -16.4% | +423.5% | -11.6% | +29.7% | -73.2% | +32.9% | -39.4% | +48.5% | +12.2% | -28.2% | +427.8% | +25.4% | -33.3% | +11.2% |
| YoY Change | — | — | — | — | -56.4% | -66.3% | -68.7% | +50.8% | +82.9% | +401.6% | +60.8% | -59.2% | -72.0% | -68.0% | +34.1% | -27.5% | +531.8% | +433.7% | +217.3% | +391.1% |
Range$51.00M – $523.00M
CAGR+5.9%
Avg YoY Growth+111.6%
Median YoY Growth+42.5%
Fair Value Measurement Disclosure at Other Companies
Frequently Asked Questions
- What is Medtronic's fair value measurement disclosure?
- Medtronic (MDT) reported fair value measurement disclosure of $388.00M in Q1 2026.
- How has Medtronic's fair value measurement disclosure changed year-over-year?
- Medtronic's fair value measurement disclosure increased by 391.1% year-over-year, from $79.00M to $388.00M.
- What is the long-term trend for Medtronic's fair value measurement disclosure?
- Over 5 years (2020 to 2025), Medtronic's fair value measurement disclosure has grown at a 11.7% compound annual growth rate (CAGR), from $201.00M to $349.00M.
- What does fair value measurement disclosure mean?
- The total value of assets and liabilities reported at current market prices.